Gosset research

Reports: ADC

Gosset reports matching these filters, newest first.

6 items Clear filters

  1. Conference

    ESMO 2026: oncology readouts

    Explore clinical results, ADC programs and emerging oncology approaches, with source-linked charts and trial context.

    • Oncology
    • ADC
    • ESMO
  2. Worked example

    Phase 1 trials of B7-H3-targeted drugs

    Every Phase 1 and Phase 1/2 trial of a B7-H3-directed drug, with modality, tumour type, geography and status.

    • Oncology
    • ADC
    • Cell therapy
    • B7-H3
  3. Worked example

    Claudin 18.2 competitive landscape

    Claudin 18.2 programs from preclinical to approval, with program profiles, trial sources and licensing context.

    • Oncology
    • Antibody
    • ADC
    • Claudin 18.2
  4. Worked example

    China-to-US ADC licensing

    China-origin ADCs in Phase 2 or 3 and their US licensing partners, with phases and downloadable data.

    • Oncology
    • ADC
    • China
    • Licensing
  5. Worked example

    B7-H3 ADCs in small cell lung cancer

    Selected Phase 3 B7-H3 ADC trials in small cell lung cancer, with trial details and downloadable data.

    • Oncology
    • ADC
    • B7-H3
    • Small cell lung cancer
  6. Undated

    Landscape

    Claudin 18.2 research landscape

    Source-linked programs, patient populations, clinical results and rights across antibodies, ADCs and cell therapies.

    • Oncology
    • Antibody
    • ADC
    • Cell therapy
    • Claudin 18.2

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call